Sleeping sickness in Uganda: a thin line between two fatal diseases
about
Loop-mediated isothermal amplification (LAMP) method for rapid detection of Trypanosoma brucei rhodesienseVariant Surface Glycoprotein gene repertoires in Trypanosoma brucei have diverged to become strain-specificThe ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!The Bidirectional Relationship between Sleep and Immunity against InfectionsGlossina fuscipes populations provide insights for human African trypanosomiasis transmission in UgandaTsetse fly saliva: Could it be useful in fly infection when feeding in chronically aparasitemic mammalian hostsEpidemiology of human African trypanosomiasisGenetic diversity and population structure of Trypanosoma brucei in Uganda: implications for the epidemiology of sleeping sickness and NaganaImprovements on restricted insecticide application protocol for control of Human and Animal African Trypanosomiasis in eastern UgandaClinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and UgandaTsetse flies: genetics, evolution, and role as vectorsCrossing institutional boundaries: mapping the policy process for improved control of endemic and neglected zoonoses in sub-Saharan Africa.Novel Financing Model for Neglected Tropical Diseases: Development Impact Bonds Applied to Sleeping Sickness and Rabies ControlControlling sleeping sickness--"when will they ever learn?".Neglected and endemic zoonoses.Outcome of acute East African trypanosomiasis in a Polish traveller treated with pentamidine.A Gambian infant with fever and an unexpected blood filmEstimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda.High levels of genetic differentiation between Ugandan Glossina fuscipes fuscipes populations separated by Lake Kyoga.Analysis of risk factors for T. brucei rhodesiense sleeping sickness within villages in south-east Uganda.Patterns in age-seroprevalence consistent with acquired immunity against Trypanosoma brucei in Serengeti lions.The burden of human African trypanosomiasisSpatial predictions of Rhodesian Human African Trypanosomiasis (sleeping sickness) prevalence in Kaberamaido and Dokolo, two newly affected districts of Uganda.Phylogeography and population structure of Glossina fuscipes fuscipes in Uganda: implications for control of tsetseGenetic diversity and population structure of the tsetse fly Glossina fuscipes fuscipes (Diptera: Glossinidae) in Northern Uganda: Implications for vector controlQuantifying the association between bovine and human trypanosomiasis in newly affected sleeping sickness areas of UgandaBayesian geostatistical analysis and prediction of Rhodesian human African trypanosomiasisAPOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis.Comparative detection of trypanosomal DNA by loop-mediated isothermal amplification and PCR from flinders technology associates cards spotted with patient blood.Predicting the effect of climate change on African trypanosomiasis: integrating epidemiology with parasite and vector biologyDiagnostic accuracy of molecular amplification tests for human African trypanosomiasis--systematic review.Human African trypanosomiasis in South Sudan: how can we prevent a new epidemic?The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseasesThe importance of veterinary policy in preventing the emergence and re-emergence of zoonotic disease: examining the case of human african trypanosomiasis in Uganda.Comparative genomics reveals multiple genetic backgrounds of human pathogenicity in the Trypanosoma brucei complex.An exploratory GIS-based method to identify and characterise landscapes with an elevated epidemiological risk of Rhodesian human African trypanosomiasis.The burden and spatial distribution of bovine African trypanosomes in small holder crop-livestock production systems in Tororo District, south-eastern Uganda.The dispersal ecology of Rhodesian sleeping sickness following its introduction to a new area.Incorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in UgandaIdentification of sVSG117 as an immunodiagnostic antigen and evaluation of a dual-antigen lateral flow test for the diagnosis of human African trypanosomiasis
P2860
Q21090125-01FBA08F-E0E6-431A-A3B3-8DB32E4822B0Q21266567-9A8CED45-7D41-48D0-8D71-28DE7FCA7D1BQ26781588-1BD9CA77-B3BA-46CA-AF7F-CA8895B028B8Q26784553-5F1199F9-FD56-4570-980A-8C6C7D0FDB50Q27012611-E87571A6-18B5-4447-969E-2E60BADDEC8EQ27024973-03E886C2-83CF-4CFA-BBF9-AA28D2665A01Q27026504-45829B57-16CD-4BC7-B6A5-4B2BA6F68623Q27304672-85705533-B3B9-4DFD-82AA-62AF52B5DBB3Q27304760-27584436-DC4D-473F-8783-E4D76C4F4844Q28477304-5FBAD13A-7924-4F27-8DB2-E97AA18A48B3Q28755223-A3A73166-75E7-48A5-B882-216BC9F90878Q30364448-53540531-D8C1-41CE-8169-197179513D70Q30380130-FC813DDF-745F-453C-9AA4-2DE25EF2EB2CQ30984063-CAF21079-1F27-499D-90F9-5D2274AF0388Q31080510-56CEF6CF-598A-41E3-9936-1AED7EBD5A1DQ31151922-E57A5071-51ED-4F3D-9767-B72C88AC7E7CQ33258475-674F545E-70F5-4C54-8EF6-D902C91D7E12Q33325763-8CADFD71-B38C-4F33-ABEE-59CC4D640843Q33338453-B968B476-477C-47AC-9D80-C0F1DA07B509Q33347875-BF5FD2A3-B09D-46BA-B08B-D0A5CDF7AA16Q33391046-034D698C-AEEE-4AA6-8D02-5A3E32C5A314Q33395338-A46FEA77-544F-4C05-AB6E-B56C7C17DBDFQ33519079-2AA429E6-9749-4451-9A4D-74FCD72790C7Q33543067-DADAE5D4-281F-4155-A0FB-4F831E47D4C9Q33657997-A9ED32E0-DC56-4E18-A81E-6E765083B0E2Q33716697-3FB00369-A4EF-4F0F-BDAD-CE9C1441FD7DQ33784178-2EF350F0-3CA8-4BB2-A981-A56E70785C26Q33866444-B78A478C-2EF4-406C-BC46-86A93768653DQ33909354-BBD883EC-41F6-4FF2-8134-8DD9D916D1B4Q34071252-2A1303E8-F831-4DED-B272-6A4B433328DCQ34131218-543F8ED9-DB1C-471D-9857-D4100762131CQ34293008-89176925-5323-4EF6-AED3-E76D0FDB7B67Q34335313-A856B6CD-3422-456C-B73D-4AF04ECEA913Q34441555-D8F7BAD4-1984-49CC-8C6A-B311649CFBA9Q34472594-E4658EAA-F1E5-4AD2-A946-3788C5F504B3Q34484423-C8C84482-513E-40FE-B59B-E6952E8FE312Q34989334-0994451F-FD38-413F-9AF3-274BF637E1B4Q35018959-F80C915C-6151-49DC-BCBA-BB1AB1372081Q35097828-4043C3A2-1B2D-4C29-B917-5E30E0CDB854Q35208326-655BF05A-9EA4-468F-B234-4BD678AEA425
P2860
Sleeping sickness in Uganda: a thin line between two fatal diseases
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Sleeping sickness in Uganda: a thin line between two fatal diseases
@ast
Sleeping sickness in Uganda: a thin line between two fatal diseases
@en
Sleeping sickness in Uganda: a thin line between two fatal diseases
@nl
type
label
Sleeping sickness in Uganda: a thin line between two fatal diseases
@ast
Sleeping sickness in Uganda: a thin line between two fatal diseases
@en
Sleeping sickness in Uganda: a thin line between two fatal diseases
@nl
prefLabel
Sleeping sickness in Uganda: a thin line between two fatal diseases
@ast
Sleeping sickness in Uganda: a thin line between two fatal diseases
@en
Sleeping sickness in Uganda: a thin line between two fatal diseases
@nl
P2093
P2860
P50
P1433
P1476
Sleeping sickness in Uganda: a thin line between two fatal diseases
@en
P2093
Ian Maudlin
Kim Picozzi
Martin Odiit
P2860
P304
P356
10.1136/BMJ.331.7527.1238
P407
P577
2005-11-01T00:00:00Z